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Abstract
Leber’s hereditary optic neuropathy (LHON)  is a rare maternally inherited disease caused  by 
mitochondrial DNA point mutations in genes encoding the MT-ND1, MT-ND4, MT-ND4L and MT-
ND6 subunits of complex I in the mitochondrial respiratory chain. The most common mutations 
G11778A in MT-ND4 gene, G3460A in MT-ND1 gene and T14484C in MT-ND6 gene cause 
the disease in 90% of patients but there are also a number of less common mutations. LHON is 
characterized by  bilateral acute or subacute optic neuropathy and usually occurs in young males. 
The common age at onset of visual failure is in second or third decade. The visual acuity is markedly 
diminished and the typical perimetric  nding is bilateral central scotoma. Ophthalmoscopy reveals 
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optic disc hyperemia, tortuous, telangiectatic peripapillary retinal vessels in the acute stage of 
LHON but bilateral optic atrophy after the acute stage is present. Recently the synthetic analogue 
of coenzyme Q10 Idebenone is  an approved drug for LHON patients. Idebenone acts as an electron 
carrier transferring electrons directly to the complex III of the mitochondrial respiratory chain. In this 
way the production of mitochondrial adenosine triphosphate increases and the retinal ganglion cells 
are protected from oxidative damage.
Key words: Leber’s hereditary optic neuropathy, neuro-ophthalmological symptomatology, 
genetic  investigation
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